Role Of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors In The Modulation Of QTc Interval And Ventricular Arrhythmia In Patients With Diabetes Mellitus Combined With Hypertension And Coronary Artery Disease
SGLT2 inhibitors effectively shorten QTc interval, reduce ventricular arrhythmia and cardiovascular risks in DM-HTN-CAD patients and show favorable safety for clinical reference.
Publication Details
- Journal
- Pakistan Journal of Pharmaceutical Sciences
- Published
- 2026-03-21
- DOI
- https://doi.org/10.36721/pjps.2026.39.5.reg.15600.1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00